Cytori awarded NIH Grant to develop cell-based treatments for vascular disease

21-Sep-2007

Cytori Therapeutics was awarded a $250,000 NIH (National Institutes of Health) Grant to develop adipose-derived regenerative cells as a treatment for vascular disease.

Regenerative cells within adipose (fat) tissue include adult stem cells and other cell types that have been shown to increase blood flow in and around damaged and oxygen deprived tissues. As a result, these cells hold exciting potential for the treatment of vascular conditions such as peripheral arterial disease, atherosclerosis, and critical limb ischemia, which impact millions of patients each year worldwide.

Other news from the department research and development

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance